Sruthi Ravindranathan

5PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersMolecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 29, 2024
VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer.

Tenzin Passang, Shuhua Wang, Hanwen Zhang

|Oct 27, 2022
Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma.

Sruthi Ravindranathan, Tenzin Passang, Jian-Ming Li

|Apr 20, 2022
Donor plasmacytoid dendritic cells limit graft-versus-host disease through vasoactive intestinal polypeptide expression.

Jingru Zhu, Yitong Wang, Jingxia Li

|Jan 27, 2022
PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity.

Christopher Ronald Funk, Shuhua Wang, Kevin Z Chen

|Dec 22, 2018
Oligoclonal T Cells Transiently Expand and Express Tim-3 and PD-1 Following Anti-CD19 CAR T Cell Therapy: A Case Report.

Christopher Ronald Funk, Christopher T Petersen, Neera Jagirdar

Pageof 1

Frequent Collaborators

4 joint publications

Edmund K Waller

3 joint publications

Hanwen Zhang

2 joint publications

Christopher Ronald Funk

2 joint publications

Gregory B Lesinski